Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. - Wikidata - wikimedia - TriplyDB

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.

http://www.wikidata.org/entity/Q37207105

about

Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management Clinical and serological evaluation of a novel CENP-A peptide based ELISA Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations.Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).Mechanisms of Autoantibody-Induced Pathology.Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon.Aldolase predicts subsequent myopathy occurrence in systemic sclerosis The Clinical Features of Myositis-Associated Autoantibodies: a Review.Diagnostic profile on the IFA 40: HEp-20-10 - an immunofluorescence test for reliable antinuclear antibody screening.Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort.Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment.Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects.The changing landscape of the clinical value of the PM/Scl autoantibody system.Muscle involvement in systemic sclerosis: points to consider in clinical trials.Disease-related autoantibody profile in patients with systemic sclerosis.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.Bench to bedside review of myositis autoantibodies.

P2860

Q28392431-892C1E5B-9CDA-4852-ADDE-7773C4E05B24 Q28750130-50F2E247-2DC6-4A8A-A625-957D6CE86015 Q31125829-9EE552E0-2886-4574-BB87-B4989EAF3E61 Q33427917-7F79D4B8-8C3C-47BD-BF6F-54C6285A9650 Q33737250-C22427E4-9603-414A-88B4-AFE33370C614 Q33740580-EF6C3CF2-8790-4C1E-9244-FEF82EED9BE7 Q35532333-0F6A75BB-5E0C-41E9-8A1C-787811B80481 Q35668003-55F03D77-76C0-472B-A111-3046309F77B1 Q36246152-CE2F685A-EE78-47AB-A1D7-C333C7490F30 Q38603422-A4A13C7E-6E38-4916-9AC9-26D60D18F844 Q38926484-23227983-F80D-4E48-942D-B7615858B8A7 Q40176801-D99C3892-3CBE-4545-8856-5074831FECA9 Q40292542-314819B9-2B98-4BC2-AD28-3C0067423F31 Q40579823-4D9C3B8C-E20C-40A3-A616-0BB131900D73 Q43120878-FB8246F8-7DAF-4D13-8F53-315694A9305E Q46256178-50D51874-60D4-47E5-A08E-24DAE64753D1 Q47685250-B83C1283-060D-4522-A1C8-92CD79CE8AB7 Q52597638-675472A8-1F4C-41B8-B716-AC3866A09A47 Q53388034-C7C33907-A392-4885-8181-15971FC4F679 Q54374398-1891DB2B-D097-416D-9B37-509E29DFA989 Q55425108-29A3BF57-8C2C-4FB9-A8D3-FE6DA0DA2757

P2860

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.

http://www.wikidata.org/entity/Q37207105

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antibodies against PM/Scl-75 a ...... f systemic sclerosis patients.

@en

Antibodies against PM/Scl-75 a ...... f systemic sclerosis patients.

@nl

type

label

Antibodies against PM/Scl-75 a ...... f systemic sclerosis patients.

@en

Antibodies against PM/Scl-75 a ...... f systemic sclerosis patients.

@nl

prefLabel

Antibodies against PM/Scl-75 a ...... f systemic sclerosis patients.

@en

Antibodies against PM/Scl-75 a ...... f systemic sclerosis patients.

@nl

P1433

Q37207105-47F8339A-39CE-491E-BA9D-FB86714D63D0

P1476

Q37207105-4F890642-0AD3-4638-B90D-0E20BD909DE1

P2093

Q37207105-1AEF2992-F663-41D6-A633-30E9597BF972

Q37207105-20776510-9D44-478A-8F81-5CF92244D6B8

Q37207105-259A5C96-9142-40E5-AFEB-A34D40F29C2C

Q37207105-38BFD440-A46D-4E97-B834-2781C9BD04C0

Q37207105-3BED7F47-FC54-4803-B4DC-C10DA5705DEA

Q37207105-424EC0E0-3E7B-4E13-9C84-F68B155491FE

Q37207105-5EA87BE8-E690-4618-930E-0337356CB435

Q37207105-6754357C-D715-4183-9FC8-9CBE6CD50102

Q37207105-95535E32-516E-47AD-96C8-744D4ED38657

Q37207105-9B5F6C2D-4946-4F3D-9205-9F8A6344AA2F

P2860

Q37207105-02A72EBA-9F78-47A3-9FBC-45AAD313590A

Q37207105-110875BC-F01E-419B-B913-B913334A31A2

Q37207105-45E665A0-6E4D-4478-9937-B5FD2540DA97

Q37207105-4B5D29B6-058F-40AF-AA6A-0956B0C40BD2

Q37207105-6FC23F16-E69E-42BC-A6DE-2B7E5CE7464F

Q37207105-77D62EA7-2F7D-4EC0-A400-FB2263FF9F07

Q37207105-89CE7279-7B2E-4372-A03E-6752BD44FACE

Q37207105-8BE9F8CC-F4B7-46D5-86AD-FABA2847AE84

Q37207105-8D514A40-5301-462F-8CC5-3D2EB032D85C

Q37207105-8D770B82-4E62-49C2-ABA0-599AEE2D339D

P2888

Q37207105-AAF35F42-3129-482B-9D28-29BE5D616B73

P304

Q37207105-0A28497B-2AD1-4E30-99CE-36BECF064362

P31

Q37207105-F935272E-B4F0-4589-8F53-14B841231CB9

P356

Q37207105-236CDADD-0EEE-4E43-B6CA-D7E2883CEB2E

P433

Q37207105-78DA5586-DDFD-412A-811D-0F8E90229A9E

P478

Q37207105-877BEB17-6EB8-4C1A-BDCD-0B40AAF16EB9

P50

Q37207105-03F8E2E6-2071-495B-9669-9784F1E66640

Q37207105-4991C7CA-953B-42B6-84FD-EF9A398895F3

Q37207105-590FB116-9D42-469D-8C80-D1A45751AC7A

Q37207105-690B8AE3-7889-40E6-B3E5-954DFE9A3C93

Q37207105-6C5B1790-231E-4516-A6AF-1B1937BE77B9

P577

Q37207105-ED14A976-08CB-48EC-AC55-515FC0186F7C

P5875

Q37207105-8362CE90-15C6-49A3-A071-56C1645F95EC

P6179

Q37207105-B5E53A85-F298-4C2E-AECB-8DA76BE6DE65

P698

Q37207105-21B08AB0-2B59-427F-AEA3-2FD9F881A363

P921

Q37207105-E87EC089-53DC-40B7-B759-1300F2C19C42

P932

Q37207105-9AB8B761-0DAE-45AB-A477-C65ABFD2FBDB

P356

P1433

Arthritis Research and Therapy

P1476

Antibodies against PM/Scl-75 a ...... f systemic sclerosis patients.

@en

P2093

Angela Kill

http://www.w3.org/2001/XMLSchema#string

Anthonia Janssen

http://www.w3.org/2001/XMLSchema#string

Claudia S Brückner

http://www.w3.org/2001/XMLSchema#string

Cornelia Dähnrich

http://www.w3.org/2001/XMLSchema#string

Dörte Huscher

http://www.w3.org/2001/XMLSchema#string

Falk Hiepe

http://www.w3.org/2001/XMLSchema#string

Katharina Hanke

http://www.w3.org/2001/XMLSchema#string

Lars Komorowski

http://www.w3.org/2001/XMLSchema#string

Marina Backhaus

http://www.w3.org/2001/XMLSchema#string

Mike Becker

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibodies directed to novel components of the PM/Scl complex, the human exosome

The association of the human PM/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus

Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen

Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein

Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights

PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome

The 1982 revised criteria for the classification of systemic lupus erythematosus

Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria.

P2888

P304

R22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2614

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Gabriela Riemekasten

Gerd-Rüdiger Burmester

Cornelia Dähnrich

P577

2009-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24019014

http://www.w3.org/2001/XMLSchema#string

P6179

1030139507

http://www.w3.org/2001/XMLSchema#string

P698

19220911

http://www.w3.org/2001/XMLSchema#string

P921

P932

2688254

http://www.w3.org/2001/XMLSchema#string